Ordaōs Selected to Participate in the AWS Generative AI Accelerator
NEW YORK, May 31, 2023 /PRNewswire/ -- Ordaōs , a human-enabled, machine-driven drug design company that creates novel and customized mini-proteins, today announced it has been selected to participate in the inaugural cohort of the AWS Generative AI Accelerator , a technical, business, and mentorship program for generative AI-focused startups to help accelerate their cloud-native business.
- NEW YORK, May 31, 2023 /PRNewswire/ -- Ordaōs , a human-enabled, machine-driven drug design company that creates novel and customized mini-proteins, today announced it has been selected to participate in the inaugural cohort of the AWS Generative AI Accelerator , a technical, business, and mentorship program for generative AI-focused startups to help accelerate their cloud-native business.
- The AWS Generative AI Accelerator is a technical and business mentorship program focused on providing founders of early-stage startups using generative AI to solve complex problems with access to training, mentorship, tools, and resources to turbocharge their cloud-native businesses.
- The AWS Generative AI Accelerator program will help fuel Ordaōs' efforts to enhance its technological capabilities, while also exploring new collaborations with organizations working to positively impact human health.
- For more information on the AWS Generative AI Accelerator, visit https://aws-startup-lofts.com/amer/program/accelerators/generative-ai .